✓ Credit card payment restored — secure checkout via Privacy Shield
Morgan Ellis, pharmacy researcher and medical reviewer at MedsBase

Medically reviewed by  ·  Last reviewed: May 2026

Morgan Ellis

Pharmacy Researcher · 8 years experience

Pharmacy researcher with 8 years reviewing clinical drug information, generic formulation equivalence, and international pharmaceutical standards. Focuses on patient-facing accuracy in medication education.

Key Takeaways — Livalo (Pitavastatin)

  • Livalo is the brand name for pitavastatin, a statin (HMG-CoA reductase inhibitor) approved to lower LDL cholesterol and reduce cardiovascular risk.
  • Pitavastatin is one of the least studied statins — atorvastatin and rosuvastatin have decades of large outcome-trial data; pitavastatin’s landmark REAL-CAD trial (21,000 patients) is the main evidence base.
  • No widely available generic in the US — Livalo costs $300–$500+ per month at US pharmacies. Generic pitavastatin exists but is still expensive ($150–$250/month).
  • Atorvastatin and rosuvastatin generics offer equivalent or superior LDL reduction at a fraction of the price and with far more clinical outcome data.
  • MedsBase offers WHO-GMP generic statins from $18: Atorvatin (atorvastatin), Crestor (rosuvastatin), and Simvatic (simvastatin).

What Is Livalo?

Livalo is the US brand name (Kowa Pharmaceuticals) for pitavastatin calcium, a synthetic statin available in 1 mg, 2 mg, and 4 mg tablets. Like all statins, it works by inhibiting HMG-CoA reductase — the rate-limiting enzyme in the liver’s cholesterol production pathway — and is indicated for adults with primary hyperlipidaemia or mixed dyslipidaemia who require LDL reduction to lower cardiovascular risk.

Pitavastatin was approved by the FDA in 2009 and is also sold as Zypitamag (another brand). Outside the US it is available under trade names including Livalo, Pitava, and Pivast in Japan, South Korea, and Europe. In Japan — where the drug was first developed — it remains widely used. Western adoption has been slower, largely because atorvastatin and rosuvastatin already dominate with extensive outcome data.

How Pitavastatin Works

Pitavastatin competitively inhibits HMG-CoA reductase, blocking the conversion of HMG-CoA to mevalonate — the first committed step in cholesterol biosynthesis. The resulting drop in hepatic cholesterol triggers upregulation of LDL receptors on liver cells, which pull more LDL particles out of circulation. Net effect: lower LDL-C, lower triglycerides, and a modest rise in HDL-C.

Clinical spotlight — Why is pitavastatin different?

Pitavastatin is minimally metabolised by CYP450 enzymes (unlike atorvastatin via CYP3A4 or simvastatin via CYP3A4). This gives it a lower drug–drug interaction burden in polypharmacy patients. It also shows a more favourable HDL-raising effect in some studies — an advantage that remains debated clinically. However, these properties have not translated into superior hard outcomes over atorvastatin or rosuvastatin in direct head-to-head trials.

Livalo Dosing

DoseLDL Reduction (approximate)Intensity
1 mg/day~30%Low-to-moderate
2 mg/day~36–38%Moderate
4 mg/day~39–44%Moderate-to-high

Maximum dose is 4 mg/day. Unlike simvastatin (which has an 80 mg dose limit due to myopathy risk), pitavastatin’s ceiling is relatively low — and its maximum LDL reduction (~44%) is modest compared to atorvastatin 40–80 mg (~50–55% reduction) or rosuvastatin 20–40 mg (~52–63% reduction).

Livalo Side Effects

Pitavastatin shares the class-wide side-effect profile of all statins:

  • Myalgia (muscle aching) — most common complaint; 5–10% of patients report some degree; severe myopathy or rhabdomyolysis is rare (<0.1%)
  • Raised liver enzymes (ALT/AST) — mild, usually transient; severe hepatotoxicity is very rare
  • New-onset diabetes — class effect; higher-intensity statins carry slightly higher risk
  • Headache, constipation, nasopharyngitis — reported in clinical trials

Pitavastatin’s minimal CYP3A4 metabolism means fewer interactions with drugs like HIV antiretrovirals, azole antifungals, and macrolide antibiotics — a genuine advantage in complex polypharmacy cases.

Livalo Cost — And Why It’s a Problem

In the United States, Livalo (branded pitavastatin) costs $350–$550 per month without insurance, and generic pitavastatin (Zypitamag) is still $150–$250/month at most US pharmacies. This places pitavastatin among the most expensive statins — despite offering no proven clinical outcome superiority over generic atorvastatin or rosuvastatin, which cost $4–$30/month in the US and significantly less internationally.

The cost-efficacy gap. A meta-analysis of 14 randomised trials (Comparative effectiveness of statins, BMJ 2014) found atorvastatin and rosuvastatin achieve greater percentage LDL reductions than pitavastatin at their respective doses, with far more cardiovascular outcome trial data. Unless you have a specific clinical reason (CYP450 interactions, tolerability issues with other statins), the cost premium for Livalo is difficult to justify based on evidence alone.

Livalo vs Other Statins — Head-to-Head

StatinMax LDL ReductionCV Outcome TrialsGeneric Cost (approximate)CYP450 Metabolism
Livalo (Pitavastatin)~44%REAL-CAD (one large trial)$150–$250/mo (US)Minimal (CYP2C9 minor)
Atorvastatin~55%CARDS, ASCOT-LLA, TNT, ASTEROID$4–$18CYP3A4 (major)
Rosuvastatin~63%JUPITER, HOPE-3, CORONA$6–$45CYP2C9 (minor)
Simvastatin~47%4S, HPS (massive)$4–$30CYP3A4 (major)

Cheaper Alternatives to Livalo Available at MedsBase

If you are taking pitavastatin for cost reasons, or looking for a more evidence-backed statin at a fraction of the price, these WHO-GMP certified generics are worth discussing with your doctor:

Top Statin Alternatives at MedsBase

  • Atorvatin (Atorvastatin) — from $18 — High-intensity statin; most prescribed in the world; 55% max LDL reduction; backed by CARDS, TNT, and ASCOT outcome trials
  • Crestor (Rosuvastatin) — from $45 — Highest potency statin per mg; 63% max LDL reduction; lowest muscle side-effect rate among high-intensity statins; JUPITER trial data
  • Simvatic (Simvastatin) — from $31 — One of the longest-studied statins (4S trial, 1994; HPS 2002); moderate intensity; max 40 mg (80 mg not recommended due to myopathy risk)

Who Should Consider Sticking With Pitavastatin?

There are specific patient populations where pitavastatin’s unique profile is genuinely useful:

  • HIV patients on protease inhibitors — many HIV drugs are CYP3A4 inhibitors, dramatically raising simvastatin and atorvastatin levels. Rosuvastatin is usually preferred, but pitavastatin is an alternative when rosuvastatin interaction is also a concern.
  • Patients with proven intolerance to CYP3A4-metabolised statins — if atorvastatin and simvastatin caused myalgia despite dose reduction, pitavastatin or rosuvastatin may be better tolerated.
  • Low HDL with normal LDL — pitavastatin has the most consistent HDL-raising effect among statins; useful where HDL elevation is a primary goal.

For the vast majority of patients who simply need LDL lowering for cardiovascular risk reduction, atorvastatin 10–40 mg or rosuvastatin 10–20 mg delivers superior or equivalent LDL reduction with decades of outcome data, at a cost that is 10–30× lower than branded Livalo.

Switching From Livalo to a Generic Statin — What to Know

Switching statins is clinically straightforward and routinely done. Key points:

  • Allow 6–8 weeks after switching before re-checking LDL to allow the new statin to reach steady state
  • Dose equivalence is approximate — your doctor may adjust based on your target LDL and response
  • If you experienced muscle symptoms on one statin, report them to your doctor before switching; some patients are statin-sensitive rather than specific-statin-sensitive
  • Rosuvastatin and pitavastatin share a similar CYP profile (both minimal CYP3A4) — rosuvastatin is often the most logical switch for patients on pitavastatin due to drug interactions

Frequently Asked Questions

Is Livalo better than atorvastatin?

Not meaningfully for most patients. Atorvastatin achieves greater maximum LDL reduction (55% vs 44%), has far more cardiovascular outcome trial data, and costs 10–30× less. Pitavastatin has a minor advantage in drug–drug interactions (less CYP3A4 metabolism) and may be preferred in HIV patients on certain antiretrovirals.

Is there a generic version of Livalo?

Yes — generic pitavastatin (Zypitamag is one branded generic) is available in the US, but still costs $150–$250/month. Compare this to generic atorvastatin at $4–$18 or rosuvastatin at $6–$45. The savings from switching to atorvastatin or rosuvastatin generics are substantial.

Does Livalo cause less muscle pain than other statins?

There is no strong clinical trial evidence that pitavastatin causes significantly fewer muscle symptoms than atorvastatin or rosuvastatin at equivalent doses. Some observational studies suggest a favourable tolerability profile, but this has not been confirmed in large head-to-head RCTs. If you experience myalgia on any statin, dose reduction or switching molecules is the recommended approach.

Can I order statin generics online without a prescription?

MedsBase offers WHO-GMP certified atorvastatin, rosuvastatin, and simvastatin generics with worldwide shipping. Statins are long-term medications — always take them under medical supervision and have your LDL monitored every 3–6 months.

How does pitavastatin compare to rosuvastatin?

Rosuvastatin is more potent (63% max LDL reduction vs 44% for pitavastatin), also has minimal CYP3A4 metabolism (similar low interaction profile), and has multiple large cardiovascular outcome trials (JUPITER, HOPE-3). For the vast majority of patients, rosuvastatin is the preferred choice when CYP3A4 interactions are a concern and high-intensity statin therapy is needed.

What is the REAL-CAD trial?

REAL-CAD (2018, N=13,054, Japan) is the primary cardiovascular outcome trial for pitavastatin. It showed pitavastatin 4 mg reduced MACE compared to pitavastatin 1 mg in stable coronary artery disease — importantly, this was a dose-comparison trial, not a comparison against atorvastatin or rosuvastatin. It confirmed high-dose pitavastatin is beneficial but does not establish superiority over other high-intensity statins.

Medical Disclaimer: This article is for informational purposes only. Statins are prescription medications that require medical supervision. Do not start, stop, or change your statin without discussing with your doctor. LDL targets and statin choice depend on your cardiovascular risk, other medications, and medical history.

Sophie Chen

Written by

Sophie Chen

Pharmaceutical Content Researcher · 8 years experience

Sophie Chen is a pharmaceutical content researcher with 8 years covering generic medication access and clinical pharmacology. She specialises in international regulatory frameworks, bioequivalence standards, and patient-facing education on therapeutic drug classes. She is not a clinician.

Leave a Reply

Your email address will not be published. Required fields are marked *